Evaluation of Linezolid Pharmacokinetics in Critically Ill Obese Patients with Severe Skin and Soft Tissue Infections

Linezolid standard dosing is fixed at 600 mg every 12 h (q12h) for adults. Literature suggests critically ill, obese patients require higher doses. The study aim is 2-fold: (i) to describe linezolid pharmacokinetics (PK), and (ii) to evaluate if PK/pharmacodynamic (PD) target attainment is achieved...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Blackman, Alison L., Jarugula, Praneeth, Nicolau, David P., Chui, Sai Ho, Joshi, Manjari, Heil, Emily L., Gopalakrishnan, Mathangi
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2021
Matèries:
Clinical Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7848975/
https://ncbi.nlm.nih.gov/pubmed/33257446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01619-20
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars